Bianca Romo
Bianca’s studies focus on the identification and functional analysis of novel protein modulators of estrogen receptor alpha in breast cancer cells.
Steven Tau
Steven is leveraging metabolic and REDOX vulnerabilities in residual breast cancers cells that remain following anti-estrogen therapy to develop novel therapeutic approaches.
Anneka Johnson
Anneka is exploring the role of epigenetics in the therapeutic response to estrogen in breast cancer. She completed her B.S. in Biochemistry & Molecular Biology at the University of Wisconsin at Eau Claire in 2019. She then joined the Cancer Biology PhD program in the Guarini School of Graduate and Advanced Studies at Dartmouth College and is completing her thesis work in the Miller Lab.
Abby Goen
Abby is developing therapeutic strategies targeting fat metabolism in breast cancer cells.
Alyssa Roberts
Alyssa aims to uncover mechanisms of DNA damage in breast cancer and explore novel combination therapies to treat recurrent disease. She received her B.S. in Biochemistry from North Dakota State University in 2021 before starting her Ph.D. in Cancer Biology at Dartmouth.
Lauren Ferridge
Lauren is evaluating the effects of oxidative stress in ER+ breast cancer.
Alexa Warren
Alexa is exploring the molecular mechanisms that underly the sensitivity of breast cancer cells to novel treatment combinations designed to overcome resistance to current therapies.
